Equity Overview
Price & Market Data
Price: $0.367
Daily Change: -$0.0131 / 3.57%
Range: $0.35 - $0.38
Market Cap: $18,101,754
Volume: 611,763
Performance Metrics
1 Week: -3.94%
1 Month: 53.75%
3 Months: -41.05%
6 Months: -97.19%
1 Year: -96.90%
YTD: -96.82%
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: other
Country: United States
Details
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, engages in development and marketing of disruptive technology for novel sublingual delivery mechanisms in the United States. The company offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. It also develops formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, the company develops formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. Aspire Biopharma Holdings, Inc. was founded in 2021 and is headquartered in Humacao, Puerto Rico.